These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33465605)

  • 1. Hepatitis C virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico.
    Wagner K; Zhong Y; Teshale E; White K; Winstanley EL; Hettema J; Thornton K; Bisztray B; Fiuty P; Page K
    Drug Alcohol Depend; 2021 Mar; 220():108527. PubMed ID: 33465605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016-2018.
    Gupta A; Shebl FM; Tong Y; Wagner K; Bassett IV; Page K; Winstanley EL
    Addict Sci Clin Pract; 2022 Oct; 17(1):58. PubMed ID: 36266666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
    Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
    Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015.
    Abara WE; Trujillo L; Broz D; Finlayson T; Teshale E; Paz-Bailey G; Glick S; Al-Tayyib AA; Robinson WT; Masiello-Schuette S; Sey EK; Anderson BJ; Poe J; Braunstein S
    J Infect Dis; 2019 Jul; 220(3):377-385. PubMed ID: 30915477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
    Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
    Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
    Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
    Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
    Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
    Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cascade of Care for Hepatitis C Virus Infection Among Young Adults Who Inject Drugs in a Rural County in New Mexico.
    Carmody MD; Wagner K; Bizstray B; Thornton K; Fiuty P; Rosario AD; Teshale E; Page K
    Public Health Rep; 2023; 138(6):936-943. PubMed ID: 36633367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
    Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and associated risk factors of hepatitis C antibody and RNA among people who inject drugs in Puerto Rico.
    Aponte-Meléndez Y; Eckhardt B; Fong C; Padilla A; Trinidad-Martínez W; Maldonado-Rodríguez E; Agront N; Mateu-Gelabert P
    J Subst Use Addict Treat; 2024 May; 160():209308. PubMed ID: 38301921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.
    Fortier E; Artenie AA; Zang G; Jutras-Aswad D; Roy É; Grebely J; Bruneau J
    Addiction; 2019 Aug; 114(8):1495-1503. PubMed ID: 30957310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndemic factors associated with non-fatal overdose among young opioid users in New York City.
    Guarino H; Frank D; Quinn K; Kim D; Gile K; Ruggles K; Friedman SR; Mateu-Gelabert P
    Front Public Health; 2023; 11():1195657. PubMed ID: 37435512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study of hepatitis C prevalence and correlates among persons who inject drugs in rural and non-rural communities.
    Barranco MA; Rosenberg ES; Flanigan C; Shufelt S; Bruce EM; Wilberschied LA; Parker MM; Duncan E; Udo T
    J Viral Hepat; 2022 Nov; 29(11):994-1003. PubMed ID: 35925950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States.
    Romo E; Stopka TJ; Jesdale BM; Wang B; Mazor KM; Friedmann PD
    Harm Reduct J; 2024 Jan; 21(1):23. PubMed ID: 38282000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018.
    Des Jarlais DC; Arasteh K; McKnight C; Feelemyer J; Perlman DC; Tross S
    Drug Alcohol Depend; 2019 Nov; 204():107459. PubMed ID: 31521951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics.
    Zibbell JE; Hart-Malloy R; Barry J; Fan L; Flanigan C
    Am J Public Health; 2014 Nov; 104(11):2226-32. PubMed ID: 25211717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.
    Puzhko S; Roy É; Jutras-Aswad D; Artenie AA; Fortier E; Zang G; Bruneau J
    Int J Drug Policy; 2017 Sep; 47():61-68. PubMed ID: 28666636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.
    Garfein RS; Rondinelli A; Barnes RF; Cuevas J; Metzner M; Velasquez M; Rodriguez D; Reilly M; Xing J; Teshale EH
    J Urban Health; 2013 Jun; 90(3):516-28. PubMed ID: 22766605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.